Literature DB >> 12776199

LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21.

Claudia Ruivenkamp1, Mario Hermsen, Cindy Postma, Anita Klous, Jan Baak, Gerrit Meijer, Peter Demant.   

Abstract

Recently, the gene PTPRJ (protein tyrosine phosphatase receptor type J) was identified as the candidate gene for the mouse colon cancer susceptibility locus Scc1. Its human homologue PTPRJ is frequently deleted in several cancer types, including colorectal cancer. To elucidate the role of PTPRJ loss in different stages of colorectal cancer and in its pathways of progression, we expanded the previously published comparative genomic hybridization results with novel data on loss of heterozygosity (LOH) at the PTPRJ locus. We identified a strong association between the LOH of PTPRJ and the loss of chromosomal region 18q12-21 (P=0.009). This observation is specific for progressed colorectal adenomas, suggesting that an interaction between LOH of PTPRJ and loss of 18q12-21 may be involved in the development of a more progressed form of adenomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12776199     DOI: 10.1038/sj.onc.1206246

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  29 in total

1.  Low-resolution structure and fluorescence anisotropy analysis of protein tyrosine phosphatase eta catalytic domain.

Authors:  Huita C Matozo; Maria A M Santos; Mario de Oliveira Neto; Lucas Bleicher; Luís Mauricio T R Lima; Rodolfo Iuliano; Alfredo Fusco; Igor Polikarpov
Journal:  Biophys J       Date:  2007-03-30       Impact factor: 4.033

2.  Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.

Authors:  Marjo van Puijenbroek; Jan Willem F Dierssen; Patrick Stanssens; Ronald van Eijk; Anne Marie Cleton-Jansen; Tom van Wezel; Hans Morreau
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

3.  TCPTP regulates SFK and STAT3 signaling and is lost in triple-negative breast cancers.

Authors:  Benjamin J Shields; Florian Wiede; Esteban N Gurzov; Kenneth Wee; Christine Hauser; Hong-Jian Zhu; Timothy J Molloy; Sandra A O'Toole; Roger J Daly; Robert L Sutherland; Christina A Mitchell; Catriona A McLean; Tony Tiganis
Journal:  Mol Cell Biol       Date:  2012-11-19       Impact factor: 4.272

4.  Early genetic aberrations in patients with sporadic colorectal cancer.

Authors:  Brooke R Druliner; Xiaoyang Ruan; Hugues Sicotte; Daniel O'Brien; Hongfang Liu; Jean-Pierre A Kocher; Lisa Boardman
Journal:  Mol Carcinog       Date:  2017-10-18       Impact factor: 4.784

Review 5.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

6.  An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis.

Authors:  Gabi Tarcic; Shlomit K Boguslavsky; Jean Wakim; Tai Kiuchi; Angela Liu; Felicia Reinitz; David Nathanson; Takamune Takahashi; Paul S Mischel; Tony Ng; Yosef Yarden
Journal:  Curr Biol       Date:  2009-11-17       Impact factor: 10.834

7.  NMD inhibition fails to identify tumour suppressor genes in microsatellite stable gastric cancer cell lines.

Authors:  Tineke E Buffart; Marianne Tijssen; Jamila El-Bchiri; Alex Duval; Mark A van de Wiel; Bauke Ylstra; Gerrit A Meijer; Beatriz Carvalho
Journal:  BMC Med Genomics       Date:  2009-06-29       Impact factor: 3.063

8.  Phosphatome profiling reveals PTPN2, PTPRJ and PTEN as potent negative regulators of PKB/Akt activation in Ras-mutated cancer cells.

Authors:  Jasminka Omerovic; Michael J Clague; Ian A Prior
Journal:  Biochem J       Date:  2010-01-27       Impact factor: 3.857

9.  The protein tyrosine phosphatase receptor D, a broadly inactivated tumor suppressor regulating STAT function.

Authors:  Timothy A Chan; Adriana Heguy
Journal:  Cell Cycle       Date:  2009-10-08       Impact factor: 4.534

Review 10.  Mouse models for the study of colon carcinogenesis.

Authors:  Daniel W Rosenberg; Charles Giardina; Takuji Tanaka
Journal:  Carcinogenesis       Date:  2008-11-26       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.